Stay updated with breaking news from Nasdaq Tern. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Terns Pharmaceuticals (NASDAQ:TERN – Free Report) had its price target upped by Mizuho from $16.00 to $17.00 in a research note issued to investors on Wednesday, FlyOnTheWall reports. Several other research firms have also recently issued reports on TERN. Roth Mkm reissued a buy rating and set a $23.00 target price on shares of Terns […]
Terns Pharmaceuticals (NASDAQ:TERN – Free Report) had its target price trimmed by HC Wainwright from $11.00 to $8.00 in a report issued on Wednesday morning, MarketBeat Ratings reports. The brokerage currently has a neutral rating on the stock. HC Wainwright also issued estimates for Terns Pharmaceuticals’ Q3 2023 earnings at ($0.33) EPS, Q4 2023 earnings […]
Terns Pharmaceuticals (NASDAQ:TERN – Get Free Report) had its target price reduced by equities researchers at HC Wainwright from $11.00 to $8.00 in a report issued on Wednesday, FlyOnTheWall reports. HC Wainwright’s target price would suggest a potential upside of 24.42% from the company’s previous close. TERN has been the subject of a number of […]
Senthil Sundaram Stepping Down as Chief Executive Officer for Health Reasons...
Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Free Report) have been given a consensus rating of “Moderate Buy” by the nine research firms that are presently covering the firm, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. […]